Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections

Abstract

Implementing a PNA FISH test to identify Candida species from yeast-positive blood cultures in conjunction with a pharmacy-driven antimicrobial stewardship protocol decreased the time to targeted antifungal therapy and the time to culture clearance.